Ironwood Financial, llc - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 160 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.

Quarter-by-quarter ownership
Ironwood Financial, llc ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q1 2017$41,000
+32.3%
3,1500.0%0.03%
+22.7%
Q4 2016$31,000
-18.4%
3,1500.0%0.02%
-18.5%
Q3 2016$38,000
+40.7%
3,1500.0%0.03%
+35.0%
Q2 2016$27,000
-10.0%
3,1500.0%0.02%
-13.0%
Q1 2016$30,000
-28.6%
3,1500.0%0.02%
+9.5%
Q3 2015$42,000
-40.8%
3,1500.0%0.02%
-38.2%
Q2 2015$71,000
+57.8%
3,1500.0%0.03%
+54.5%
Q1 2015$45,0003,1500.02%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
SNYDER CAPITAL MANAGEMENT L P 4,324,232$165,185,6623.73%
Steamboat Capital Partners, LLC 196,898$7,521,5042.79%
2Xideas AG 600,799$22,950,5222.54%
BERNZOTT CAPITAL ADVISORS 171,808$6,563,0662.26%
Redwood Investments, LLC 328,459$12,547,1341.70%
Mesirow Institutional Investment Management, Inc. 380,415$14,531,8531.47%
Granite Investment Partners, LLC 856,253$32,708,8651.37%
Penn Capital Management Company, LLC 324,707$12,453,2111.28%
EFG Asset Management (North America) Corp. 137,739$5,262,3191.25%
First Light Asset Management, LLC 313,536$11,977,0751.14%
View complete list of HALOZYME THERAPEUTICS INC shareholders